Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kathryn M. Headley"'
Autor:
Kathryn M. Headley, Katarzyna M. Kedziora, Aidin Alejo, Elianna Zhi-Xiang Lai, Jeremy E. Purvis, Nathaniel A. Hathaway
Publikováno v:
Stem Cell Research, Vol 38, Iss , Pp - (2019)
Here we utilized the chromatin in vivo assay (CiA) mouse platform to directly examine the epigenetic barriers impeding the activation of the CiA:Oct4 allele in mouse embryonic fibroblasts (MEF)s when stimulated with a transcription factor. The CiA:Oc
Externí odkaz:
https://doaj.org/article/32351aaaf3894319a827aa5bbfe3b5ad
Autor:
Wanjuan Feng, Jang-Eun Cho, Nate Hathaway, Chelsea M. Smith, Juan Carvajal-Garcia, Dennis A. Simpson, Dale A. Ramsden, Kathryn M. Headley, Gaorav P. Gupta
Publikováno v:
Nucleic Acids Research
Genome integrity and genome engineering require efficient repair of DNA double-strand breaks (DSBs) by non-homologous end joining (NHEJ), homologous recombination (HR), or alternative end-joining pathways. Here we describe two complementary methods f
Autor:
Katarzyna M. Kedziora, Kathryn M. Headley, Nathaniel A. Hathaway, Aidin Alejo, Jeremy E. Purvis, Elianna Zhi-Xiang Lai
Publikováno v:
Stem Cell Research, Vol 38, Iss, Pp-(2019)
Stem cell research
Stem cell research
Here we utilized the chromatin in vivo assay (CiA) mouse platform to directly examine the epigenetic barriers impeding the activation of the CiA:Oct4 allele in mouse embryonic fibroblasts (MEF)s when stimulated with a transcription factor. The CiA:Oc
Autor:
Bethanie L. Morrison, Joe J. Mitala, Joseph M. Reilly, Kathryn M. Headley, Kevin A. Murray, Federico Bernal, Amanda L. Whiting
Publikováno v:
Cancer Research. 74:3234-3234
Mutations in the DNA binding region of tumor suppressor p53 render it transcriptionally inactive (dominant negative) but can also manifest in transcriptionally-independent gain-of-function (GOF) effects, possibly due to mutp53 interacting with other,
Autor:
Federico Bernal, Kenneth Felsenstein, Elisabeth A. Russell, Kathryn M. Headley, Kevin A. Murray
Publikováno v:
Cancer Research. 73:2223-2223
Considered to be the “guardian of the genome,” the tumor suppressor p53 works to counteract genetic mutation through cell cycle arrest, DNA repair or apoptosis to prevent proliferation of damaged cells. Dysfunction of the p53 pathway is a large d